FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

The FDA approved a supplemental application for Ultramicrosize Griseofulvin tablets from Amneal Pharmaceuticals of New York LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatophytosis
• Tinea Capitis
• Tinea Corporis
• Tinea Cruris

Drugs mentioned

• Ultramicrosize Griseofulvin Tablets (griseofulvin)

Snippet

SUPPL AP for ULTRAMICROSIZE GRISEOFULVIN (ULTRAMICROSIZE GRISEOFULVIN TABLETS)